The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
Abstract
Gene expression signatures for a basal-like breast cancer (BLBC) subtype have been associated with poor clinical outcomes, but a molecular basis for this disease remains unclear. Here, we report overexpression of the transcription factor FOXC1 as a consistent feature of BLBC compared with other molecular subtypes of breast cancer. Elevated FOXC1 expression predicted poor overall survival in BLBC (P = 0.0001), independently of other clinicopathologic prognostic factors including lymph node status, along with a higher incidence of brain metastasis (P = 0.02) and a shorter brain metastasis–free survival in lymph node–negative patients (P < 0.0001). Ectopic overexpression of FOXC1 in breast cancer cells increased cell proliferation, migration, and invasion, whereas shRNA-mediated FOXC1 knockdown yielded opposite effects. Our findings identify FOXC1 as a theranostic biomarker that is specific for BLBC, offering not only a potential prognostic candidate but also a potential molecular therapeutic target in this breast cancer subtype. Cancer Res; 70(10); 3870–6. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Triple-negative breast cancer: clinical features and patterns of recurrence
Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091 · cited 5×
“© 2010 American Association for Cancercancerres.aacrjournals.org Downloaded from FOXC1+/ER−/PR−/HER2− samples in this cohort may reflect inconsistent expression of these cytokeratins in BLBCs defined by expression arrays (5).”
BackgroundInfluential
Cited by
Forkhead box proteins: tuning forks for transcriptional harmony.
Lam, E. W.-F., Brosens, J. J., Gomes, A. R., & Koo, C.-Y. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3539 · Cited by 684
The biology of brain metastases—translation to new therapies
Eichler, A. F., Chung, E., Kodack, D. P., Loeffler, J. S., Fukumura, D., & Jain, R. K. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.58 · Cited by 567
Current approaches to the treatment of metastatic brain tumours
Owonikoko, T. K., Arbiser, J., Zelnak, A., Shu, H.-K. G., Shim, H., Robin, A. M., Kalkanis, S. N., Whitsett, T. G., Salhia, B., Tran, N. L., et al. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.25 · Cited by 304
Breast cancer lung metastasis: Molecular biology and therapeutic implications
Jin, L., Han, B., Siegel, E., Cui, Y., Giuliano, A., & Cui, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1456599 · Cited by 295
Self-citationEssential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling
Bonnans, C., Flacelière, M., Grillet, F., Dantec, C., Desvignes, J.-P., Pannequin, J., Severac, D., Dubois, E., Bibeau, F., Escriou, V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109457109 · Cited by 49
Metadata
- Authors
- Ray, P. S., Wang, J., Qu, Y., Sim, M.-S., Shamonki, J., Bagaria, S. P., Ye, X., Liu, B., Elashoff, D., Hoon, D. S., Walter, M. A., Martens, J. W., Richardson, A. L., Giuliano, A. E., & Cui, X.
- Venue
- Cancer Research
- Published
- 2010-05-12
- Volume
- 70
- Issue
- 10
- Pages
- 3870-3876
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2151001058
- Cited by
- 231
- References
- 1
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-09-4120
- The paper
- Ray, P. S., Wang, J., Qu, Y., Sim, M.-S., Shamonki, J., Bagaria, S. P., Ye, X., Liu, B., Elashoff, D., Hoon, D. S., Walter, M. A., Martens, J. W., Richardson, A. L., Giuliano, A. E., & Cui, X. (2010). FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-09-4120
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.